
Trends Shaping The $7.5 Billion Narcolepsy Drugs Market, 2025-2033 - Surging Prevalence Of Narcolepsy And Lifestyle-...
(MENAFN- GlobeNewsWire - Nasdaq) Clinical Trials Accelerate Narcolepsy Drug Development, with Alkermes' ALKS 2680 Targeting Orexin 2 Receptor in Focus Dublin, May 01, 2025 (GLOBE NEWSWIRE) -- The "Narcolepsy Drugs Market Size and Share Analysis - …